Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
PLoS One; doi: 10.1371/journal.pone.0101643v.
Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease
International Journal of Neuropsychopharmacology; DOI: http://dx.doi.org/10.1017/S1461145713000886.
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine.
Front Aging Neurosci.; https://doi.org/10.3389/fnagi.2014.00237.
Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro
GLIA; DOI: 10.1002/glia.22619.
Zinc depletion regulates the processing and secretion of IL-1β
Cell Death & Disease; doi:10.1038/cddis.2013.547.
Aβ-specific DARPins as a novel class of potential therapeutics for Alzheimer’s disease
The Journal of Biological Chemistry; doi: 10.1074/jbc.M114.564013.
A novel cell line from spontaneously immortalized murine microglia
Journal of Neuroscience Methods; DOI: 10.1016/j.jneumeth.2014.05.021.
Testing synthetic amyloid-β aggregation inhibitor using single molecule atomic force spectroscopy
Biosensors and Bioelectronics; http://dx.doi.org/10.1016/j.bios.2013.10.060.
Is Formaldehyde the Missing Link in AD Pathology? The Differential Aggregation of Amyloid-Beta with APOE Isoforms In Vitro.
Curr Alzheimer Res.; DOI:10.2174/1567205011666140425112043.
Methylglyoxal Produced by Amyloid-β Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer's Disease
Journal of Alzheimer’s Disease; DOI 10.3233/JAD-131685.